Mean infant exposure (mg/ kg) at steady state was estimated to be 1.8% of the maternal olanzapine dose (mg/ kg).
Keskmine aine püsikontsentratsioon imikul (mg/ kg) oli 1, 8% ema olansapiini annusest (mg/ kg).